Cargando…

Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis

BACKGROUND: As transjugular intrahepatic portosystemic shunt (TIPS) creation alters the hemodynamic status of the portal system, whether reduced portal blood supply affects the synthetic reserve function of the liver has been the focus of clinical attention. Since the Viatorr stent entered the Chine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Xin, Zhou, Hao, Huang, Shan, Tang, Shan-Hong, Qin, Jian-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942045/ https://www.ncbi.nlm.nih.gov/pubmed/33728297 http://dx.doi.org/10.12998/wjcc.v9.i7.1532

Ejemplares similares

Clinical efficacy of antiviral therapy in patients with hepatitis B-related cirrhosis after transjugular intrahepatic portosystemic shunt
por: Yao, Xin, et al.
Publicado: (2021)

Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt
por: Luo, Shi-Hua, et al.
Publicado: (2017)

Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome
por: Zhou, Chun-Ze, et al.
Publicado: (2020)

Parallel transjugular intrahepatic portosystemic shunt with Viatorr(®) stents for primary TIPS insufficiency: Case series and review of literature
por: Raissi, Driss, et al.
Publicado: (2019)

Effect of VIATORR stent in early ultrasound evaluation after transjugular intrahepatic portosystemic shunt (TIPS): A case report
por: Du, Heng, et al.
Publicado: (2020)

Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy
por: Luo, Shi-Hua, et al.
Publicado: (2019)

Elective Transjugular Intrahepatic Portosystemic Shunt Using Viatorr Stent-Grafts: A Single-Center Experience from China
por: Li, Yu-Hua, et al.
Publicado: (2022)

Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency
por: Dong, Fang, et al.
Publicado: (2019)

Impressive recompensation in transjugular intrahepatic portosystemic shunt-treated individuals with complications of decompensated cirrhosis based on Baveno VII criteria
por: Gao, Long, et al.
Publicado: (2023)

Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications
por: Luo, Shi-Hua, et al.
Publicado: (2023)

Use of doppler ultrasound to predict need for transjugular intrahepatic portosystemic shunt revision
por: Duong, Nikki, et al.
Publicado: (2022)

Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation
por: Praktiknjo, Michael, et al.
Publicado: (2021)

Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma
por: Luo, Shi-Hua, et al.
Publicado: (2019)

Stent fracture after transjugular intrahepatic portosystemic shunt placement using the bare metal stent/stent-graft combination technique
por: Liu, Qi-Jia, et al.
Publicado: (2023)

Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes
por: Hsu, Michael C, et al.
Publicado: (2017)

Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt
por: He, Fuliang, et al.
Publicado: (2016)

Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020
por: Horhat, Adelina, et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt vs conservative treatment for recurrent ascites: A propensity score matched comparison
por: Philipp, Martin, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update
por: Rajesh, Sasidharan, et al.
Publicado: (2020)

Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus
por: Zhang, Yue, et al.
Publicado: (2019)

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
por: Tripathi, Dhiraj, et al.
Publicado: (2020)

Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt
por: Yang, Chongtu, et al.
Publicado: (2021)

Prognosis after splenectomy plus pericardial devascularization vs transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding
por: Qi, Wei-Li, et al.
Publicado: (2023)

Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension
por: Yan, Xuan-Hui, et al.
Publicado: (2022)

Transient Hemolytic Anemia after Transjugular Intrahepatic Portosystemic Stent Shunt
por: Garcia-Rebollo, Sagrario, et al.
Publicado: (1996)

The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips
por: Fanelli, Fabrizio
Publicado: (2014)

Transjugular intrahepatic portosystemic shunt and splenectomy are more effective than endoscopic therapy for recurrent variceal bleeding in patients with idiopathic noncirrhotic portal hypertension
por: He, Fu-Liang, et al.
Publicado: (2020)

Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis
por: Bucsics, Theresa, et al.
Publicado: (2022)

Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shunt
por: Wang, Lan-Jing, et al.
Publicado: (2023)

Dynamic changes in liver function after transjugular intrahepatic portosystemic shunt in patients with cirrhosis
por: Wang, Chaoyang, et al.
Publicado: (2022)

Parallel Shunt for the Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
por: Luo, Xuefeng, et al.
Publicado: (2013)

Severe acute alcoholic hepatitis and hepatorenal syndrome: role of transjugular intrahepatic portosystemic stent shunt
por: Testino, G, et al.
Publicado: (2012)

Transjugular intrahepatic portosystemic shunt using the FLUENCY expanded polytetrafluoroethylene-covered stent
por: WU, QINGHUA, et al.
Publicado: (2013)

Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
por: Wang, Zhong, et al.
Publicado: (2021)

Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients
por: Gou, Xiaoyuan, et al.
Publicado: (2022)

Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Refractory Transudative Chylothorax due to Liver Cirrhosis
por: Khaliq, Muhammad Farhan, et al.
Publicado: (2020)

Impact of transjugular intrahepatic portosystemic shunt creation on the central lymphatic system in liver cirrhosis
por: Pieper, Claus Christian, et al.
Publicado: (2021)

Pediatric liver cirrhosis interventional procedures: from biopsy to transjugular intrahepatic portosystemic shunt
por: Natali, Gian Luigi, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt for Budd–Chiari syndrome with diffuse occlusion of hepatic veins
por: He, Fuliang, et al.
Publicado: (2016)

Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
por: Luo, Xuefeng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r3nfmc6r1408t55bus5brhm0mp